![John S. Sundsmo](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John S. Sundsmo
Keine laufenden Positionen mehr
Profil
John S.
Sundsmo worked as the VP-Research & Intellectual Property Management at Stellar Biotechnologies, Inc. before obtaining a doctorate degree from the University of Washington.
Ehemalige bekannte Positionen von John S. Sundsmo
Unternehmen | Position | Ende |
---|---|---|
Stellar Biotechnologies, Inc.
![]() Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von John S. Sundsmo
University of Washington | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Stellar Biotechnologies, Inc.
![]() Stellar Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Stellar Biotechnologies, Inc. engages in the research, development, manufacture, and commercialization of Keyhole Limpet Hemocyanin (KLH), an immune-stimulating protein utilized as a carrier molecule in therapeutic vaccines and for assessing immune system function. Its product portfolio includes Stellar KLH Products, Stellar KLH Protein, and Stellar KLH ELISA Kits. The Company was founded in 1999 and is headquartered in Port Hueneme, CA. | Health Technology |